Breakthrough medicines. By design.

Breakthrough medicines. By design.

Breakthrough medicines.

By design.

Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration.

Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration.

Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration.

Therapeutic areas

Therapeutic areas

Cambium Bio is advancing novel therapies for:

Cambium Bio is advancing novel therapies for:

Dry Eye Disease (DED)

Dry Eye Disease (DED)

Knee Osteoarthritis

Knee Osteoarthritis

Wound healing

Wound healing

Our Science

Our Science

Cambium Bio's proprietary technology platforms harness the regenerative potential of human platelet lysate and mesenchymal stem cells to develop innovative biologic therapies. Learn more about our science

Cambium Bio's proprietary technology platforms harness the regenerative potential of human platelet lysate and mesenchymal stem cells to develop innovative biologic therapies. Learn more about our science

Our Pipeline

Our Pipeline

Cambium Bio's diversified pipeline includes:

Cambium Bio's diversified pipeline includes:

An illustration from Carlos Gomes Cabral
An illustration from Carlos Gomes Cabral
An illustration from Carlos Gomes Cabral

01.

Elate Ocular®

Elate Ocular®, a late clinical-stage asset for dry eye disease.

02.

Progenza

03.

Sygenus

An illustration from Carlos Gomes Cabral
An illustration from Carlos Gomes Cabral
An illustration from Carlos Gomes Cabral

01.

Elate Ocular®

Elate Ocular®, a late clinical-stage asset for dry eye disease.

02.

Progenza

03.

Sygenus

01.

Elate Ocular®

Elate Ocular®, a late clinical-stage asset for dry eye disease.

02.

Progenza

03.

Sygenus

Stay up to date

Stay up to date

Stay up to date

Sign up for alerts on our latest news, events, and ASX announcements.

Sign up for alerts on our latest news, events, and ASX announcements.

Sign up for alerts on our latest news, events, and ASX announcements.